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[H1]Abstract  
Studies of pediatric cardiac arrest use inconsistent outcomes, including return of spontaneous 
circulation and short-term survival, and basic assessments of functional and neurological status. 
In 2018, the International Liaison Committee on Resuscitation sponsored the COSCA initiative 
(Core Outcome Set After Cardiac Arrest) to improve consistency in reported outcomes of 
clinical trials of adult cardiac arrest survivors and supported this P-COSCA initiative (pediatric 
COSCA). The P-COSCA Steering Committee generated a list of potential survival, life impact, 
and economic impact outcomes and assessment time points that were prioritized by a 
multidisciplinary group of healthcare providers, researchers, and parents/caregivers of children 
who survived cardiac arrest. Then, expert panel discussions achieved consensus regarding the 
core outcomes, the methods to measure those core outcomes, and the timing of the 
measurements. The P-COSCA includes assessment of survival, brain function, cognitive 
function, physical function, and basic daily life skills. Survival and brain function were assessed 
at discharge or 30 days (or both if possible) and between 6 and 12 months postarrest. Cognitive 
function, physical function, and basic daily life skills were assessed between 6 and 12 months 
after cardiac arrest. Because many children have prearrest comorbidities, the P-COSCA also 
includes documentation of baseline (ie, prearrest) brain function and calculation of changes after 
cardiac arrest. Supplementary outcomes of survival, brain function, cognitive function, physical 
function, and basic daily life skills are assessed at 3 months and beyond 1 year after cardiac 
arrest if resources are available. 
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[H1]Background  
Cardiac arrest occurs in >20 000 children annually in the United States.1-7 Overall survival after 
in-hospital cardiac arrest increased from 14.3% in 2000 to 39.4% in 20098 most recent survival 
rates at 48.0%1 in the United States and from 25.9% to 41% in Spain,1,9 while survival after out-
of-hospital cardiac arrest remains low at 8.3%10 to 11.1%.1  
Survivors of cardiac arrest are at significant risk for both short-term and long-term 
morbidity.8,9,11-15 Children who survive out-of-hospital cardiac arrest can demonstrate decline in 
neurobehavioral function that is often severe.14 Many who survive cardiac arrest with a grossly 
“favorable outcome” have more subtle and sustained neuropsychological impairment.16 
Furthermore, assessment of neurodevelopmental impact of cardiac arrest is complicated by the 
presence of preexisting neurological compromise in many children who have a cardiac arrest.17 
These challenges highlight the importance of research that can precisely define, compare, and 
improve patient outcomes.14 
Outcomes reported in studies of children surviving cardiac arrest vary and include return of 
spontaneous circulation, short-term mortality, and basic assessment of functional and 
neurological outcome.18 Lack of uniformity in reported outcome assessment methods and follow-
up intervals prevents pooling of data for meta-analyses, limits generalizability of study 
conclusions, and impedes development of clinical recommendations to improve care.  
A more contemporary approach to outcomes in research studies includes clinical, clinician-
reported, and patient-/caregiver-/family-centered outcomes, neuropsychological testing, and 
evaluation and quantification of resource use and socioeconomic impact. In light of these 
developments, in 2015, the International Liaison Committee on Resuscitation (ILCOR), a 
council of the world’s resuscitation councils, expanded its recommendations for uniform 
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reporting of outcomes of adult cardiac arrest to include both core and supplementary outcomes, 
acknowledging the need to add assessment of morbidities, patient-reported outcomes, and quality 
of life (QoL) measures.19  
In 2018, to further improve consistency in reporting of outcomes of adult cardiac arrest, ILCOR 
sponsored the development of a core outcome set (COS) for adult cardiac arrest (COSCA).20,21 A 
COS is a standardized minimal set of outcomes to be reported in all effectiveness trials in a 
specialty, designed to foster consistent reporting of outcomes.22 To enhance the relevance of 
outcome assessment for policy and practice, COS development should incorporate the views of 
key stakeholders, including providers and patients. A COS constitutes the minimum reporting 
elements but does not limit the reporting of other outcomes.22 Implementation of standardized 
assessment and outcome reporting reduces heterogeneity and outcome reporting bias, improves 
comparability across studies, and enables the pooling of data for meta-analyses.  
The development of the adult COSCA included a consensus process involving the participation 
of key international stakeholders, including survivors and their partners, healthcare providers, 
and researchers who identified the key elements, tools, and the intervals for assessment. The 
COSCA includes assessment of survival and neurological function (using the modified Rankin 
Scale) at discharge or 30 days after cardiac arrest (or both if possible) and assessment of HRQoL 
(using 1 of 3 generic measures) at 90 days, with periodic reassessments through the first year if 
resources allow.  
The ILCOR P-COSCA initiative (Pediatric COSCA) sought to develop a COS specific for 
pediatric cardiac arrest studies. The design and methods of this initiative were closely aligned 
with the COSCA design and methods, including use of a Delphi process to develop consensus 
regarding a core domain set. There are important differences between pediatric cardiac arrest and 
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adult cardiac arrest in causes, treatment, and survival rates. Children are still developing and are 
normally dependent on care providers before a cardiac arrest as well as during recovery and 
ongoing development. Thus, although there may be similarities in the outcomes that are critical 
to both children and adults, there are likely important differences that should be considered in 
pediatric outcome assessment. 
[H1]Methods 
Both the COSCA and the P-COSCA initiatives used approaches from OMERACT (Outcome 
Measures in Rheumatology)23-25 and COMET (Core Outcome Measures in Effectiveness 
Trials)26 initiatives.20,21 The project was registered with the COMET initiative.27 Approval for 
survey distribution was obtained from the Children’s Hospital of Philadelphia Institutional 
Review Board.  
ILCOR appointed the P-COSCA international steering committee (SC). The SC consisted of 18 
healthcare providers, including specialists in pediatric critical care medicine, pediatric 
emergency medicine, neuropsychology, physical medicine and rehabilitation, pediatric nursing, 
clinical trials, and outcome methodology. These experts reviewed the literature, drafted the 
survey, conducted the Delphi process, reached consensus, and served as the writing group for 
this consensus statement. The American Heart Association manuscript oversight committee 
reviewed all conflicts of interest statements by the SC members before approving their 
participation. The final manuscript has been endorsed by ILCOR member councils and the 
American Heart Association’s Emergency Cardiovascular Care Science Subcommittee and 
Science Advisory and Coordinating Committee (SACC). 
There were 2 major steps in the development of the P-COSCA: 
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● Step 1: Defining the COS (ie, what—at a minimum—should be measured): The SC used the 
OMERACT framework to identify 3 core areas of health to evaluate: survival, life impact, 
and resource use/economic impact (see Figure 1).28 Although a fourth area 
(pathophysiological manifestations) is also proposed in the OMERACT framework, this was 
not included. An international Delphi process was used to refine and prioritize outcome 
domains within each core. Then, the SC identified the minimum number of outcomes to 
include in the P-COSCA.  
● Step 2: Identifying the core measurement set (ie, how and when the core outcomes should 
be measured): The SC debated the strengths and weaknesses of measurement tools 
appropriate for each selected outcome until consensus was reached. The SC then determined 
by consensus the time points for assessment. 
[h2]Step 1: Defining the COS 
[h3]Generating an Extensive List of Potential Outcomes 
At an in-person meeting in November 2018, the SC used the COSCA20,21 and SC suggestions to 
generate a comprehensive list of potential outcomes to serve as a starting point for this process. 
Potential outcomes were considered in light of the wide-ranging HRQoL needs and experiences 
of children,12 longer-term impact of cardiac arrest on childhood growth and development,29 and 
potential effects of cardiac arrest on family.30 The list of outcomes and time points for 
consideration in step 2 are listed in Figure 2.  
[h3]International Delphi Process to Refine and Prioritize Outcomes 
The SC defined 2 panels: (1) healthcare providers experienced in the care of pediatric survivors 
of cardiac arrest and (2) parents/caregivers of survivors, with a goal of 100 healthcare providers 
(based on COSCA enrollment) and 20 parents/caregivers of survivors. 
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Each SC member (n=18) invited at least 5 healthcare providers to participate in the surveys. The 
survey was only in English. To provide a multidisciplinary view, prehospital providers, nurses, 
respiratory therapists, rehabilitation service providers, psychologists, social workers, and 
physicians were included.  
To include parents/caregivers of children who survived cardiac arrest, surveys were distributed 
via survival networks in the United States and the United Kingdom (see Box) and, with 
institutional internal review board approval, at a US medical center that cares for pediatric 
cardiac arrest survivors and their families. To reach survival networks, an email was sent to the 
foundation or network contact with an attached introductory email and survey link and a request 
to forward the letter and link to parents and caregivers of survivors in the network. At the US 
institution that surveyed survivors, providers contacted eligible parents and caregivers of their 
own patients to request voluntary participation. 
The first online survey (see Appendix 1) included a list of potential outcomes and time points for 
assessment (REDCap).31 After the SC piloted the survey to ensure comprehensiveness, clarity, 
and face validity, the survey was then completed by both panels (ie, healthcare providers and 
parents/caregivers) and members of the SC.  
The Delphi process consisted of 2 sequential rounds. Respondents who completed the survey in 
round 1 were eligible to complete a survey in round 2. The group decided a priori to analyze the 
combined responses of healthcare providers and parents/caregivers. In round 1, respondents rated 
the relative importance of outcomes for inclusion in future pediatric cardiac arrest research 
studies on a 9-point numerical rating scale, ranging from a low of 1 (ie, not at all important) to a 
high of 9 (ie, very important). Respondents were asked to rate the importance of each outcome at 
3 distinct time points that were selected by SC consensus: (1) at discharge, (2) within the first 
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year after the cardiac arrest, and (3) >1 year after the cardiac arrest. Respondents could comment 
on their decisions and suggest additional important outcomes. Outcomes rated as most important 
(ie, a score of 8 or 9) by >75% of respondents were advanced to round 2 (see Figure 2). 
In round 2 (see Appendix 2), respondents first prioritized all outcomes ranging from a low of 1 
(ie, not a priority) to a high of 5 (ie, absolute priority) for assessment at each time point (ie, 
discharge, within the first year after cardiac arrest, and >1 year after cardiac arrest). Next, 
respondents ranked their top 7 highest priority outcomes at each time point (ie, outcome/time 
point combinations). Finally, respondents were asked to select the single most important 
assessment time point within the first year after the cardiac arrest and the single most important 
assessment time point >1 year after cardiac arrest.  
Results were analyzed by summarizing the scores for the top 7 prioritized outcome/time point 
combinations. Round 2 mean and standard deviation (SD) rating scores for each outcome were 
compared with the top 7 prioritized outcome/time point combinations by rank score for 
healthcare providers and parents/caregivers. The SC identified and discussed the rank score and 
mean and SD rating for all outcomes for both healthcare providers and parents/caregivers. The 
top 7 outcome/time point combinations for healthcare providers and the top 7 outcome/time 
point combinations for parents/caregivers were identified and discussed by the SC in step 2. The 
SC also considered the outcome measures as well as the respondents’ prioritization of time 
points independently. 
[h2]Step 2: Identifying the Core Measurement Set  
After the COS was identified in step 1, members of the SC then identified the core measurement 
tools and timing of those measurements (step 2) and reached consensus to create the final P-
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COSCA. This group met by webinar on 22 occasions. A final vote of approval was conducted 
with unanimity required.  
The SC first discussed the summarized survey results, including additional comments, 
acknowledging that the final COS needed to be valid, feasible, and acceptable. The SC reviewed 
measurement tools appropriate for children 0 to 18 years of age that were used in peer-reviewed 
published studies of pediatric cardiac arrest or in other relevant pediatric populations (eg, critical 
illness, neurological injury). Consensus was reached through repeated discussions, and 
unanimous agreement was achieved for final wording.  
[H1]Results 
[h2]Step1: Defining the COS 
[h3]Generating an Extensive List of Potential Outcome Domains  
The initial survey questionnaire included 18 outcomes across the 3 core areas of health: survival 
(1 outcome), life impact (16 outcomes), and resource use/economic impact (1 outcome). In 
contrast to the COSCA outcomes,20,21 the SC expanded the P-COSCA core area of life impact 
into more granular outcomes. Because children are raised by parents/caregivers, the impact of 
the child’s cardiac arrest on the family was considered in more depth, and the economic impact 
domain was refocused on the family in the P-COSCA. The SC included assessment time points 
consistent with the COSCA’s time points of at discharge and within the first year after cardiac 
arrest20,21 and also chose to include >1 year after cardiac arrest as a potential outcome 
measurement because of children’s longitudinal development (see Figure 2). 
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[h3]International Delphi Process to Refine and Prioritize Outcomes  
[h4]Round 1 
In total, 89 participants completed round 1: 83 healthcare providers (50 physicians, 7 
psychologists, 11 nurses, 7 therapists [speech, physical, occupational], 4 social workers, 1 
paramedic, and 3 not identified); and 6 parents/caregivers of children who survived cardiac arrest 
(median age of child at arrest was 11 years; median time since arrest, 3 years). Participants 
represented 12 countries (United States, United Kingdom, New Zealand, Peru, Singapore, 
Netherlands, Brazil, Canada, Belgium, Tunisia, South Africa, and Denmark). 
The SC reviewed results of round 1 and identified 22 outcome/time point combinations and 11 
unique outcomes to include in round 2 based on the combined input of healthcare providers and 
parents/caregivers (see Supplementary Table 1 and Figure 2). The respondents highly prioritized 
survival at all 3 time points (ie, hospital discharge, within the first year after cardiac arrest, and 
>1 year after cardiac arrest). Healthcare providers and parents/caregivers agreed on 10 of the 
outcome/time point combinations. Survival and brain function were the only 2 discharge 
outcomes that were ranked highly enough to be included in round 2. Parents/caregivers 
prioritized the assessment of survival, fatigue, and sleep >1 year after cardiac arrest and family 
relationships and economic impacts on the family at discharge and within the first year after 
cardiac arrest (see Supplementary Table 1). 
[h4]Round 2 
Seventy-four respondents completed round 2 (68 healthcare providers [82% response rate]; 6 
parents/caregivers [100% response rate]). The top 7 outcome/time point combinations were 
identified. Both healthcare providers and parents/caregivers prioritized survival at discharge, 
survival within the first year after cardiac arrest, brain function at discharge, and brain function 
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and cognitive function within the first year after cardiac arrest (see Supplementary Table 2). 
Healthcare providers also highly ranked cognitive function >1 year after cardiac arrest and basic 
daily life skills within the first year after cardiac arrest. Parents/caregivers also included physical 
functioning within the first year. All 8 outcome domain time point combinations were considered 
in the consensus meeting (see Figure 2). 
Hospital discharge was ranked as the highest priority time point for assessment when compared 
with the time points of within the first year and >1 year. To further identify time points for 
assessments within the first year, respondents prioritized assessments at 6 months (52%) and 1 
year (35%) higher than assessments at 3 months (13%). For time points after 1 year, the majority 
of respondents (63%) selected 2 years as the most important time point, compared with 5 years 
(34%) and 10 years (3%). Survey comments identified concerns about the feasibility and 
practicality of collecting longer-term outcomes (ie, >1 year after cardiac arrest) and noted the 
critical importance of incorporating a baseline precardiac arrest assessment of the child’s 
neurological function to better identify the impact of the cardiac arrest.  
[h2]Step 2: Identifying the Core Measurement Set  
[h3]Measuring Survival 
The SC agreed that the core outcomes should include measurement of survival to discharge from 
an acute care facility or survival at 30 days (see Table 1). The P-COSCA suggests that 
researchers report both measures if possible, documenting assessments at each time point rather 
than as a composite score, to avoid loss of granularity regarding how time impacts outcomes. 
The SC agreed to define the discharge time point as the time of discharge from the acute care 
facility associated with the hospitalization for the cardiac arrest because children surviving 
cardiac arrest may be transferred to and discharged from multiple facilities and the use of such 
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facilities may vary substantially across healthcare systems and countries. Additional variability is 
introduced by limitations of healthcare systems finances and the family’s capability to care for 
the child at home. In addition, many children with cardiac arrest have chronic medical 
conditions, preexisting comorbidities, or postarrest complications and can remain hospitalized 
for prolonged periods.17 For all these reasons, the 30-day survival outcome assessment time point 
is preferred for consistency; however, for patients who are discharged before 30 days, follow-up 
at 30 days may not be feasible due to the need for consent and loss to follow-up. As a result, the 
SC included assessment of survival at discharge or 30 days, or both if possible. The Delphi 
process also prioritized measuring survival within the first year after cardiac arrest.  
[h3]Measuring Brain Function 
In the Delphi survey, brain function was described as consciousness or awareness of 
surroundings. When considering methods to evaluate brain function, the SC discussed the 
relative merits and limitations of 2 healthcare provider-completed measures—the Pediatric 
Cerebral Performance Category (PCPC)32,33 and the Glasgow Outcome Scale–Extended Pediatric 
Revision (GOS-E Peds).34 Characteristics of these tools are listed in Table 2. The Functional 
Status Scale (FSS) was considered as a measure of brain function but not included for 3 reasons: 
(1) It does not include death in its scoring; (2) it has multiple domains not all related to brain 
function; and (3) the domains associated with brain function are too broad to capture the 
granularity of injury after cardiac arrest. The SC proposes the PCPC as the core outcome 
measure for brain function, noting that studies can use the GOS-E Peds as an additional measure.  
The SC considered several issues important in evaluation of post–cardiac arrest brain function, 
including validity and reliability in children with and without neurological deficits after cardiac 
arrest and ease of use. Both the PCPC and GOS-E Peds are tools for qualitative assessments of 
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performance that provide categorical outcome scores based on the GOS.32-34 Although similar in 
design, these tools have not been compared directly in the same patient populations. Both the 
PCPC and GOS-E Peds include death in the scaling, which the SC considered to be important 
because survey respondents prioritized assessment of survival at multiple time points. The PCPC 
was included in the 1995 Pediatric Utstein template of recommended guidelines for reporting 
outcomes of pediatric advanced life support,18,35 and it has been used extensively to measure 
cardiac arrest outcomes since that time.36-38 The GOS-E Peds has been used to measure outcomes 
after pediatric traumatic brain injury34,39 but has not yet been validated in the pediatric cardiac 
arrest population.  
As many as 56.9% of children who experience in-hospital cardiac arrest have preexisting 
neurological deficits.17 The SC agreed that it is important to include a baseline prearrest measure 
of brain function by using the same tool used for postarrest measurement to identify changes in 
neurological function after the cardiac arrest.  
Both the PCPC and GOS-E Peds have limitations. While the PCPC has been used extensively in 
pediatric cardiac arrest research, its broad category descriptions are vague and the scoring criteria 
are subjective. In comparison, the GOS-E Peds has more categorical designations than the PCPC, 
and the descriptions within each category are more detailed, but as of the time of this publication, 
there have been no published studies using the GOS-E Peds in children after cardiac arrest. The 
PCPC is currently used to retrospectively retrieve assessment information regarding prearrest 
baseline brain function through review of medical records or through interview of 
parents/caregivers. Although the GOS-E Peds incorporates baseline function in the postinjury 
assessment, it has not been validated to assess baseline brain function retrospectively or 
independently of postevent outcome. The SC proposes the use of the PCPC to assess pediatric 
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brain function after cardiac arrest because of its demonstrated utility and validity in studies of 
children after cardiac arrest and the ability to document prearrest function. 
When following older children who may be transitioning to adult care soon after cardiac arrest, 
clinicians and researchers should be aware that the Cerebral Performance Category (CPC) used 
in adults is scored differently than the PCPC.  
[h4]Timing  
Both healthcare providers and parents/caregivers identified evaluation of brain function within 
the first year after cardiac arrest as a high priority. For healthcare providers, it was the highest 
priority across all potential outcome measures and time points; for parents/caregivers, it was 
identified as the second-highest priority (second only to survival to discharge). The P-COSCA 
includes evaluation of brain function at either discharge from an acute care facility or at 30 days 
(or both) and between 6 and 12 months after cardiac arrest. 
To achieve consensus regarding the timing of assessment of brain function, the SC considered 
feasibility as well as potential influences of the child’s neurological development over time. 
Assessment of brain function within the first year allows for time to pass to enable more time for 
recovery, including potential improvement associated with rehabilitation interventions (which, 
depending on child’s age, setting, and stability, may take time to assess); reintroduction of age-
appropriate activities, such as schooling; and additional expected development in the youngest 
children, so that an expanded repertoire of skills can be assessed. However, assessment within 1 
year creates a substantial burden for investigators, with impact on study timelines, cost, and risk 
of patients lost to follow-up. The SC also acknowledged that it is reasonable to designate an 
interval rather than a discrete time point for follow-up assessments because it often takes time to 
schedule follow-up telephone calls.  
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Given recent findings from the THAPCA (Therapeutic Hypothermia After Pediatric Cardiac 
Arrest) trials indicating that 3-month outcomes are predictive of outcomes at 1 year,40 3 months 
appears to be the earliest possible time point for evaluation of brain function within the first year 
after cardiac arrest. Based on these studies, correlation between 3- and 12-month outcomes 
differed between in-hospital and out-of-hospital cardiac arrest. The SC agreed that there are 
insufficient data to confidently use 3-month outcomes as representative of later outcomes of 
cardiac arrest but agreed that this issue should be reassessed over time as more data become 
available. Thus, 3 months postarrest was identified as a supplementary time point in assessment 
of brain function, in part to encourage the development of evidence regarding the utility of this 
earlier outcome assessment.  
Assessment time points beyond 1 year after cardiac arrest were determined to be impractical or 
overly burdensome at this time. The SC unanimously agreed that it is important to understand the 
impact of pediatric cardiac arrest on long-term education and on functional and developmental 
needs as children grow into adolescence and adulthood. While assessment at later time points 
allows more time for development and recovery, particularly in the youngest children, such 
extended follow-up also places significant burden on investigators.  
[h4]How to Complete  
The PCPC and GOS-E Peds can be completed in approximately 10 minutes based on information 
obtained through direct observation of the child, a caregiver report, or a review of medical 
records.41 Providers must obtain a parent’s report of the child’s baseline pre-injury level of 
functioning as soon as possible after study enrollment to minimize recall bias.42  
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[h4]What to Report 
A primary goal of the P-COSCA is to standardize the reporting of study outcomes so that 
comparisons can be made across studies over time. Availability of baseline PCPC enables 
comparison of populations, and documentation of changes from baseline facilitates measurement 
of the impact of the cardiac arrest or interventions on each child and on the study population 
overall. Therefore, the P-COSCA includes both the prearrest PCPC and PCPC scores at each of 
the core time points (see Table 1), with reporting to include the percent of patients in each PCPC 
category as well as change in PCPC between post arrest time points and prearrest (a range of 0 to 
4 in postarrest survivors). As noted below, there are many ways that change has been 
incorporated into outcome definitions. The SC considered both how to report the PCPC as well 
as how to address definitions of favorable and unfavorable outcomes. Pediatric cardiac arrest 
studies have historically dichotomized outcomes into favorable and unfavorable categories using 
the PCPC at discharge.38,43 To include patients who have prearrest developmental delays, some 
studies have used change from baseline, defined as the difference between the postarrest and 
prearrest PCPC38,43; however, the method of incorporation of the PCPC and a change in PCPC 
have varied widely. Definitions of favorable outcome have included PCPC of 1, 2, or no change 
from baseline, as well as a PCPC of 1, 2, 3, or no change from baseline.37 Furthermore, many 
studies have included a PCPC score of 6, death, in the definition of unfavorable outcome, thus 
combining patients who die with those who survive with significant neurological morbidity. 
When considering the definition of favorable and unfavorable outcome, the SC could not reach 
consensus regarding the optimal definitions of these outcomes and noted that the view of 
favorable may vary among families and even across cultures.  
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[h3]Measuring Cognitive Function, Physical Function, and Basic Daily Life Skills  
Cognitive function was defined as ability to think, concentrate, or pay attention or to think clearly 
and remember things. Compromise in physical function was defined as difficulty with eyesight; 
loss of muscle strength or mobility, such as crawling or walking; chronic headaches; or seizures. 
Basic daily life skills were defined as age appropriate eating, washing, dressing, toileting, 
personal hygiene, and getting out of bed. While these domains are unique, they are presented 
together in this section because they can often be measured by using the same tools.  
The SC prioritized review of the FSS44; the Pediatric Quality of Life Inventory (PedsQL)45; the 
Vineland Adaptive Behavior Scales, Second Edition (VABS-II)46; the Vineland Adaptive 
Behavior Scales, Third Edition (Vineland-3)47; and the Adaptive Behavior Assessment System, 
Third Edition (ABAS-3).48 Aspects of each of these tools are highlighted in Table 3. Other tools 
to assess these skills (eg, PROMIS [Patient-Reported Outcomes Measurement Information 
System], Health Utilities Index) were not examined because they did not include assessment 
information for the full pediatric age range.  
The FSS44 was developed to provide a more granular assessment of outcome than the combined 
outcomes obtained by using the PCPC.32 It includes categorical ratings within 6 functional 
domains (mental status, sensory function, communication, motor function, feeding, and 
respiratory function). The PCPC and the FSS are closely associated in pediatric intensive care 
unit patients, and relationships were even stronger when a subset of the FSS that focuses on 
neurological functioning (a composite of the mental status and communication domains) was 
compared with the PCPC.49 
The PedsQL 4.0 Generic Core Scales and the extension for young children, the PedsQL Infant 
Scales, are HRQoL measures.45,50 The PedsQL 4.0 Generic Core Scales,45 a caregiver-proxy 
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measure for children 2 to 18 years of age, consists of 4 outcome sections, including Physical, 
Emotional, Social, and School Functioning. It is a reliable and valid tool to assess children with 
numerous health conditions, including cardiac disease51,52 and acquired neurological 
conditions.53 The PedsQL Infant Scales50 consist of 5 scales, including Physical, Emotional, 
Social, and Cognitive Functioning as well as Physical Symptoms and is designed for caregiver-
proxy rating of children from 1 month to 24 months of age. Both generic and the infant versions 
have good reliability and validity in children receiving inpatient care.54 In addition to the core 
scales, condition-specific modules/scales that can be used to complement the Generic Core 
Scales for specific clinical populations. Because the PedsQL Generic Core and Infant Scales do 
not include a scale specifically measuring cognitive functioning and basic daily life skills for all 
age groups, several other PedsQL condition-specific scales were reviewed. The PedsQL 
Cognitive Functioning Scale has been validated in children with acquired neurological 
conditions,53 neurodevelopmental disabilities,55 and chronic health conditions.56 The Daily 
Activities Scale from the Cerebral Palsy (CP) Module of the PedsQL has been validated in 
children with CP, but only for those ≥2 years of age.57 Normative data have been published for 
healthy children for all scales, and the scales have been translated into many languages.45,50,51,58 
The ABAS-3 is a caregiver-report measure of functional skills.48 There is one form for children 0 
to 5 years of age and another for those 5 to 21 years of age. Key skills areas include 
communication, functional academics (pre-academics for younger children), self-direction, 
leisure, social, community use, home living, health and safety, and self-care. Scores are 
calculated for each area, and the user also calculates 3 composite scores (Conceptual, Social, 
Practical) and an overall Global Adaptive Composite score. Only the form for children ages 0 to 
5 years includes a motor scale. Both forms take approximately 15 to 20 minutes to complete. The 
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ABAS-3 is sensitive to impairment in children with acquired neurological injury.59 Standardized 
age-corrected scores are available.  
The VABS-II and recently updated Vineland-3 are caregiver-report measures that assess 
adaptive functioning in detail in individuals with neurodevelopmental disabilities. These 
measures provide scores for an overall adaptive behavior composite and 4 domains 
(communication, daily living, socialization, motor skills). Each domain includes subdomains that 
are developmentally sequenced items, starting with skills typical of infancy. Both measures have 
demonstrated high reliability and validity.46,60 Normative data obtained in a large sample of 
children from the United States are used to yield standardized age-corrected scores for the 
overall composite and for each domain. The VABS-II has been used as a primary outcome 
assessment tool in pediatric cardiac arrest studies.42,61  
The SC discussed these measures at length and evaluated each measure in relation to cognitive, 
physical, and basic daily life skills as defined above. Although use of the FSS is highly feasible 
in a pediatric intensive care unit population, it is not included in the P-COSCA because it does 
not report cognitive function, physical function, or basic daily life skills at as granular a level as 
some alternative scoring systems that have been applied to cardiac arrest survivors. The ABAS-3 
was also thought to lack feasibility because it takes up to 20 minutes to administer, and physical 
functioning is only measured in the youngest children. The VABS-II and Vineland-3 assess 
cognition, physical function, and basic daily life skills, but these measures lacked feasibility 
because they can take up to 45 minutes to administer.  
The P-COSCA proposes the Physical Functioning Scale from the PedsQL Generic Core and 
Infant Scales to measure physical functioning and the PedsQL Cognitive Functioning Scale58 for 
children ≥2 years of age, along with the Cognitive Functioning Scale of the PedsQL Infant 
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Scales for children <2 years of age (see Table 1). There were no feasible measures to assess basic 
daily life skills for all age groups. Therefore, the Daily Activities Scale from the PedsQL CP 
Module for children ≥2 years of age is included in the P-COSCA.57 The VABS-II, Vineland-3, 
and ABAS-3 are included as supplementary outcome measurement tools for cardiac arrest 
studies. 
[h3]Timing  
The SC agreed that it is important to measure cognitive function, physical function, and basic 
daily life skills between 6 and 12 months after the cardiac arrest, at the same time that brain 
function is assessed. The P-COSCA includes assessments at 3 months and 12 months post–
cardiac arrest as supplementary.  
[h3]How to Complete 
The PedsQL Generic Core, Infant, Cognitive Functioning Scales, and CP Module Daily 
Activities Scale are questionnaires that were developed to be completed directly by the caregiver. 
Paper and pencil, online, and telephone administration yield highly consistent in pediatric 
populations.62 Telephone administration has been used to determine pre-injury baseline 
functioning and outcomes in children with neurological injury over the first year after injury.53 
[h3]What to Report 
The P-COSCA includes assessment of PedsQL physical function scale and cognitive function 
scale. Since the physical function scale is part of the Generic Core Scales, researchers may 
choose to use the full age-appropriate core measure and report the complete PedsQL total 
summary score and psychosocial health summary score in addition to the physical functioning 
scale. Additionally, given that basic daily life skills were identified as a key outcome, researchers 
can use the Daily Activities Scale of the CP Module for children ≥2 years of age. 
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Within each scale, all PedsQL items have 5 options, corresponding to scores of 0, 25, 50, 75, or 
100. Higher scores indicate better HRQoL or better functioning. For each scale, the mean score 
is reported. The psychosocial health summary score is the mean score of all items within the 
emotional, social, and school functioning scales. The physical health summary score is the same 
as the physical functioning scale score. The total scale score is the mean score for all items on 
the entire scale. For all scores, means are calculated by including only completed items. If a scale 
has >50% missing items, the scale score should not be calculated.  
[H1]Discussion  
The P-COSCA Steering Committee identified a COS for research involving children surviving 
cardiac arrest. This COS includes 5 outcomes: survival, brain function, cognitive function, 
physical function, and basic daily life skills. The P-COSCA includes assessment of survival 
status and brain function by using the PCPC at discharge or 30 days after the cardiac arrest (or 
both if possible), and again between 6 and 12 months after cardiac arrest. In addition, assessment 
of prearrest baseline brain function is included. Other COS outcomes (cognitive function, 
physical function, and basic daily life skills) are also evaluated between 6 and 12 months after 
cardiac arrest by using the PedsQL and additional modules. If resources are available, 
investigators may also include other assessments at 3 months after cardiac arrest and >1 year 
after cardiac arrest. Lastly, the use of the GOS-E Peds to assess brain function and the PCPC and 
the VABS-II, Vineland-3, or ABAS-3 to assess adaptive function are supplementary outcomes 
measures, depending upon availability and feasibility.  
With this consensus statement, the P-COSCA initiative broadens the descriptions of pediatric 
cardiac arrest outcomes in 3 key ways. First, the P-COSCA initiative provides a standardized 
platform of outcomes, measures, and time points for assessment that improves the ability to 
Topjian - 22 
 
compare results across studies and to analyze results via meta-analyses and systematic reviews. 
Next, the P-COSCA improves the utility of future studies by including assessment of prearrest 
brain functioning and identification of a change in this function after cardiac arrest. This is of 
particular importance in pediatrics because a high percentage of children who develop cardiac 
arrest, particularly in the hospital, have preexisting conditions.17 Previous studies that have 
explicitly excluded children with baseline neurological deficits are not representative of the 
cardiac arrest population and may not convey an accurate representation of the extent and scope 
of cardiac arrest outcomes in the pediatric population. Accounting for prearrest baseline function 
may reduce bias toward the appearance of poor post–cardiac arrest brain function that may be 
attributable to prearrest co-morbidities rather than to the cardiac arrest itself. Including this 
baseline measure of neurological function will enhance our understanding of the full scope of 
outcomes after pediatric cardiac arrest. The survey participants clearly conveyed that assessment 
of survival and brain function are not sufficient measures of the sequelae of cardiac arrest. They 
noted that measures of HRQoL, such as cognitive function, physical function, and basic daily life 
skills, are also important. Thus, inclusion of these outcomes in the P-COSCA may provide a 
more complete picture of the consequences of pediatric cardiac arrest and required interventions.  
The P-COSCA was viewed as an extension of the COSCA, not a separate initiative; therefore, 
the outcomes of the COSCA Delphi were considered when designing outcomes that should be 
considered for the P-COSCA. Both COSs included assessment of survival and neurological 
function at discharge or 30 days (or both if possible). However, key differences emerged. The 
COSCA focused on HRQoL and provided 3 potential options for assessment after 90 days and 
then every year after, if feasible. The P-COSCA evaluated HRQoL with more granular 
subcomponents, and like the COSCA, the P-COSCA sought to evaluate longer term outcomes 
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pending resource availability. However, in contrast to the COSCA, the P-COSCA includes 
assessment of neurological function between 6 and 12 months after cardiac arrest and beyond the 
first year after cardiac arrest, if possible. This focus on neurological assessment and the longer 
timeframe was intentional because children may have ongoing brain development occurring 
independent of the cardiac arrest that affects brain and cognitive function. The P-COSCA, unlike 
the COSCA, also included a baseline neurological function assessment because many children 
who have a cardiac arrest have developmental abnormalities even before their arrest.17 
A recent American Heart Association scientific statement proposed guidelines for studies of 
neurological prognostication in comatose adult and pediatric survivors of cardiac arrest.63 This 
statement noted the challenge in neurological prognostication created by ongoing brain 
development in infants and children (especially to the age of 6 years). Many of the follow-up 
assessment time points proposed in the neurological prognostication statement were taken into 
consideration and are consistent with the P-COSCA, such as the inclusion of assessment of 
neurological outcome at hospital discharge or 1 month; and both statements include additional 
assessments during the first year. The neurological prognostication statement proposes 
neurological and HRQoL assessments at 3 months, 6 months, and 1 year for all ages and 
additional annual neurodevelopmental assessments for children until 3 years of age. There are 
important differences between the purposes and methods of the neurological prognostication 
statement and the P-COSCA statement that account for differences in the proposed timing of 
outcomes assessments. First, the neurological prognostication statement focuses on assessment 
of only those patients who are comatose after cardiac arrest, while the P-COSCA focuses on 
evaluation of core outcomes for all cardiac arrest studies involving all survivors. Second, 
development of the P-COSCA used a Delphi approach involving almost 100 healthcare providers 
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and parent/caregivers to garner their input, so it reflects a wide scope of outcome priorities. 
Third, identification of the P-COSCA highly weighted feasibility when selecting outcome 
measures and assessment time points. Although the approaches of these 2 scientific statements 
differ, the intent of the 2 documents is similar, and they are designed for distinct but 
complementary study populations.  
We acknowledge several limitations of the P-COSCA initiative. Given the difficulty in obtaining 
parental involvement despite multiple attempts to invite enrollment, these recommendations 
were disproportionately representative of the priorities of healthcare providers. However, the 
Delphi process, a priori, attempted to account for what was most important to each stakeholder 
group. Another limitation inherent to the P-COSCA initiative is related to feasibility challenges 
of longitudinal outcomes study design; multiple time points and assessments beyond 1 year after 
arrest pose significant practical challenges for obtaining data, with the potential for loss of 
patients to follow-up. The P-COSCA outcomes measures were selected with attention to the 
measures that are currently available and that are feasible and practical to administer.  
This COS is the next step in defining standardized outcomes for pediatric cardiac arrest studies, 
building on the work of the Utstein publication over 20 years ago.18 The SC envisions the P-
COSCA as the start of a dynamic, iterative process in which current gaps can be addressed. The 
OMERACT Filter 2.0 framework includes the core area of resource use/economic impact, which 
was not included in either the COSCA or P-COSCA. Similarly, the influence of the child’s 
neurodevelopmental trajectory on outcomes and determination of the optimal time points to 
assess a child’s recovery were not fully addressed. The P-COSCA acknowledges the importance 
of evaluating outcomes beyond the first year after the cardiac arrest. Because it is unclear how 
age at the time of cardiac arrest impacts longer-term outcomes and lifelong function and 
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development, outcome should be evaluated at key milestones to understand which cardiac arrest 
survivors will eventually be able to live independently and work. Finally, the SC acknowledges 
the need to understand the impact of cardiac arrest from the perspective of the patient. A 
validation of the P-COSCA is warranted in a larger cohort of family and patients. 
[H1]Conclusions 
With the support of ILCOR, a multidisciplinary group of healthcare providers and group of 
parents/caregivers defined a P-COSCA, which includes assessment of survival and brain 
function, as measured by using the PCPC at discharge from acute-care hospitalization or 30 days 
after arrest or both if feasible. The P-COSCA also includes retrospective assessment of prearrest 
brain function obtained via PCPC as soon as possible after arrest. In addition, the P-COSCA 
includes assessment of brain function, cognitive function, and physical function for all children 
and basic daily life skills for those ≥2 years of age between 6 and 12 months after arrest by using 
the PCPC and specific PedsQL scales. Supplementary reporting of the GOS-E Peds, VABS-II, 
Vineland-3, and ABAS-3 can be included if resources are available. Future additions of 
outcomes assessment tools and time points beyond the first year after cardiac arrest, when 
feasible, will enhance our understanding of pediatric outcomes after cardiac arrest.  
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Box, Tables, and Figures 
Box. Survivor networks in the United States and the United Kingdom that were contacted to 
distribute surveys to parents of children who survived cardiac arrest.  
United States  
Sudden Cardiac Arrest Foundation 
Sudden Cardiac Arrest Association 
Nick of Time Foundation 
Adamsheart Foundation  
Parent Heart Watch 
Simon’s Heart 
Minnesota SCA Survivor Network 
United Kingdom 
Sudden Cardiac Arrest UK 
https://www.suddencardiacarrestuk.org/  
SCA indicates sudden cardiac arrest. 
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Table 1. Core Areas, Outcomes, Measures, Time Points, and Methods for Collection 
Core Areas Outcomes 
(Domains) 
Measure Time Point Methods 
 Survival Survival  Hospital discharge or 30 d after 




Between 6–12 mo after cardiac 
arrest 
 Life impact Brain 
function 
 PCPC Prearrest baseline 
Caregiver report 
Medical records 
Hospital discharge or 30 d after 
cardiac arrest (or both if possible) 
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Scales (<2 y) 








CP indicates cerebral palsy; PCPC, Pediatric Cerebral Performance Category; PedsQL, Pediatric 
Quality of Life Inventory. 
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brain injury; modified 
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GOS-E Peds indicates Glasgow Outcome Scale–Extended Pediatric Revision; PCPC, Pediatric 
Cerebral Performance Category. 
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Table 3. Characteristics of Tools Considered to Measure Cognitive Functioning, Physical 
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starting with skills 
















































areas and 3 major 















areas, and all 
domains  
No 
ABAS-3 indicates Adaptive Behavior Assessment System, Third Edition; CP, cerebral palsy; 
FSS, Functional Status Scale; HRQoL, health-related quality of life; PedsQL, Pediatric Quality 
of Life Inventory; VABS-II, Vineland Adaptive Behavior Scales, Second Edition; Vineland-3, 
Vineland Adaptive Behavioral Scales, Third Edition.
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Figure 1. OMERACT Filter 2.0 framework modified for pediatric cardiac arrest. OMERACT 
indicates Outcome Measures in Rheumatology; PICU, pediatric intensive care unit; ROSC, 
return of spontaneous circulation. Reprinted from Boers et al.28 Copyright © 2014, the authors. 
https://creativecommons.org/licenses/by-nc-nd/3.0/.  
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>1 y after 
cardiac 
arrest 







Brain function ●x ●x ●xo 
Cognitive thinking function  ●x ●xo 
Communication  ●xo ●xo 
Physical function  ●xo ●xo 
Fatigue   o 
Sleep   o 
Emotional well-being  ●x ●xo 
Behavioral control    
Basic daily life skills  ●x ●x 
Activities     
Education and school function    ●x 
Social skills and relationships   ●xo ●x 
Future potential    
Daily family/household 
activities 
   
Family participation in leisure 
and social activities  
   
Family relationships  o ●x ●xo 
Economic 
impact 
Economic impact on the family  o o ●x 
Figure 2. Domains and time points presented in the initial survey were developed in step 1. An x 
indicates healthcare provider responses; o, parent/caregiver responses of >75% to round 1 of the 
survey; ●, outcomes and time points selected for round 2 of the survey based on >75% of 
responses of critical importance by healthcare providers and/or parents/caregivers. Gray boxes 
indicate domains and time points discussed at the SC consensus meeting to review results of 
survey.  
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